Folgen
Gul Naz Fatima
Gul Naz Fatima
Zugehörigkeit unbekannt
Keine bestätigte E-Mail-Adresse
Titel
Zitiert von
Zitiert von
Jahr
4-Thiazolidinones: the advances continue…
AC Tripathi, SJ Gupta, GN Fatima, PK Sonar, A Verma, SK Saraf
European Journal of Medicinal Chemistry 72, 52-77, 2014
3582014
Assessment of Awareness of Osteoporosis Amongst Unmarried Indian Girl Students Pursuing Undergraduate and Postgraduate Professional Courses
M Srivastava, GN Fatima, R Srivastava, MM Singh
Asian J Oral Health Allied Sci 3 (1), 2, 2013
112013
Vaccines in breast cancer: challenges and breakthroughs
GN Fatima, H Fatma, SK Saraf
Diagnostics 13 (13), 2175, 2023
72023
Sonar P K Verma A Saraf S K Eur
ACGSJ Tripathi, GN Fatima
J. Med. Chem 72, 52, 2014
52014
Synthesis and Antimicrobial Activity of Some Novel 7-Chloro-4-aminoquinoline Derivatives
GN Fatima, SK Paliwal, SK Saraf
Russian Journal of General Chemistry 91, 285-293, 2021
32021
In-Situ Gels for Brain Delivery: Breaching the Barriers.
GN Fatima, P Maurya, SK Saraf
Current Pharmaceutical Design, 2023
12023
New Non-Carboxylic Acid Chalcones as Anti-Inflammatory Agents: Molecular Docking, Synthesis and Admet Studies
D Pant, V Kumar, S Pandey, GN Fatima, SK Saraf
Pharmaceutical Chemistry Journal 57 (4), 507-512, 2023
2023
Vaccines in Breast Cancer: Challenges and Breakthroughs. Diagnostics 2023, 13, 2175
GN Fatima, H Fatma, SK Saraf
2023
Small Heterocyclic Molecules as Anticancer Agents: Design, Synthesis, and Evaluation Against MCF-7 Cell Lines
R Varshney, V Kumar, GN Fatima, SK Saraf
Russian Journal of General Chemistry 93 (1), 97-107, 2023
2023
Novel 2-aminopyrimidine Schiff bases as possible GABA-AT inhibitors: molecular docking, MAOS, and pharmacological screening
P Jaisal, GN Fatima, SK Vishwakarma, V Kumar, S Pandey, SK Saraf
Medicinal Chemistry Research 31 (10), 1818-1829, 2022
2022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–10